KI-Beratung Beta

Produktbild: Advanced Cancer Therapeutics

Advanced Cancer Therapeutics Strategies and Technologies for Targeted Drug Delivery

211,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

07.09.2026

Herausgeber

Manish Kumar + weitere

Verlag

Elsevier

Seitenzahl

860

Maße (L/B/H)

23,5/19,3/4,2 cm

Gewicht

1719 g

Sprache

Englisch

ISBN

978-0-443-44185-1

Beschreibung

Portrait

Manish Kumar holds the position of Assistant Professor at Amity Institute of Pharmacy in the Greater Noida Campus of Amity University. He completed his doctoral degree at the Indian Institute of Technology (Banaras Hindu University), Varanasi-221005, India. He possesses over 8 years of academic research experience. His research interests are controlled drug delivery systems, nanoemulsions, polymeric nanoparticles, lipid nanoparticles, nanocrystals, nanofibrous scaffolds, hydrogel, and microneedles for treating cancer, wounds, and inflammatory diseases. To date, he has authored over 40 peer-reviewed articles and more than 25 book chapters that have been published in well-known international journals

Abhishek Jha is an Assistant Professor at the Department of Pharmaceutics, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pune, Maharashtra. He did his Ph.D. and M.Pharm from the Indian Institute of Technology (Banaras Hindu University), India. He has more than 8 years of professional experience in academic research. His field of research includes the development of novel drug delivery technologies for controlled, targeted, and localized delivery of therapeutics for various ailments, including but not limited to cancer, wounds, and inflammatory diseases. So far he has contributed in more than dozens of peer-reviewed articles and more than 25 book chapters published in reputed international journals.

Dr. Brahmeshwar Mishra is a Professor of Pharmaceutics at the Indian Institute of Technology (BHU) in Varanasi, with over 40 years of experience in teaching and research. He has served as the Chairman of the Medical Board at IIT (BHU) from June 2012 to 2023. His expertise lies in the formulation of controlled and novel drug delivery systems, including nanoformulations, focusing on bioavailability and pharmacokinetics. He has supervised over 30 doctoral candidates and nearly 100 postgraduate students, publishing around 300 articles, 226 abstracts, 43 book chapters, and holding 3 patents.

He is a leading researcher in drug delivery. He has received numerous awards, including the Best Young Pharmacy Teacher Award and the Pharmacy Excellence Award. Additionally, he has served on editorial boards, traveled internationally for talks, and participated in various academic committees and programs.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

07.09.2026

Herausgeber

Verlag

Elsevier

Seitenzahl

860

Maße (L/B/H)

23,5/19,3/4,2 cm

Gewicht

1719 g

Sprache

Englisch

ISBN

978-0-443-44185-1

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Advanced Cancer Therapeutics
  • I. UNDERSTANDING THE CANCER
    1. Introduction to cancer
    2. Current practices in cancer chemotherapy
    3. Emerging trend in anticancer drug delivery
    4. Cancer therapy depending on tumor stroma
    5. Cancer therapy depending on cancer cell respiration: pH and hypoxia
    6. Cancer therapy depending on tumor vasculature and EPR effects.
    7. Cancer therapy based on extracellular matrix
    8. Heterogenicity of cancer and drug resistance
    II. STRATEGIES AND TECHNOLOGIES FOR CANCER THERAPY
    9. Materials and strategies for advanced anticancer drug delivery
    10. Drug Conjugates for anticancer drug delivery
    11. Self-assembled supramolecular systems for anticancer drug delivery
    12. Advances in metal-organic frameworks for anticancer drug delivery
    13. Tumor microenvironment targeted drug delivery systems
    14. Advances in dendrimers for anticancer drug delivery
    15. Advances in metallic nanoparticles for anticancer drug delivery
    16. Advances in polymeric nanoparticles for anticancer drug delivery
    17. Advances in lipid-based nanoparticles for anticancer drug delivery
    18. Advances in SNEDDS for anticancer drug delivery
    19. Advances in nanocrystals for anticancer drug delivery
    20. Theranostic nanoparticles for advanced cancer therapy
    21. DNA-based nanomaterials for anticancer therapy
    22. Nanofibrous scaffolds for cancer management
    23. Advances in hydrogel for anticancer drug delivery
    24. Advances in inorganic nanocarriers for anticancer drug delivery
    25. Microparticles for anticancer drug delivery
    26. Microneedles for anticancer drug delivery
    27. Implants for anticancer drug delivery
    28. Phytomedicine for cancer therapy
    29. Enzyme-prodrug as advanced cancer therapeutics
    III. CLINICAL STATUS, CHALLENGES AND FUTURE PROSPECTIVES
    30. Clinical status of anticancer drug delivery systems
    31. Challenges and future prospectives in anticancer drug delivery
    32. Regulatory considerations for anticancer drug delivery systems